Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Eur Arch Otorhinolaryngol. 2021 Dec;278(12):4943-4950. doi: 10.1007/s00405-021-06721-9. Epub 2021 Mar 6.
The aim of this study was to evaluate the influence of preoperative tracheotomy on oncologic outcomes of advanced stage glottic carcinoma patients, and to explore the potential reason.
We retrospectively analyzed 413 consecutive advanced stage glottic carcinoma patients from January 2005 to December 2010. The correlation of preoperative tracheotomy and potential impacting factor of tumor size involving tumor diameter and tumor area with overall survival (OS) and disease-free survival (DFS) was fully assessed.
Our cohort consisted of 302 (73.1%) patients with T3 and 111 (26.9%) patients with T4, and 98 (23.7%) patients received preoperative tracheotomy. The OS and DFS rates of patients receiving preoperative tracheotomy were worse than those without (5-year OS: 49.3% versus 69.8%; 5-year DFS: 45.3% versus 61.0%). The mean tumor diameter and tumor area of patients with preoperative tracheotomy were greater than those without (3.3 cm versus 2.4 cm, 8.9 cm versus 4.7 cm). The optimal cutoff values of tumor diameter and tumor area for tracheotomy were 2.85 cm and 6.64 cm. Tumor diameter and tumor area were correlated with tracheotomy intervention. Furthermore, when considering the potential effect of tumor area in multivariate model, we found that it was a significant factor in survival outcomes but variable of preoperative tracheotomy was not.
This study indicates that tumor size is correlated with preoperative tracheotomy, and tracheotomy intervention may be reflection from effect of great tumor size that is a true adverse factor influencing oncologic outcomes of advanced stage glottic carcinoma patients.
本研究旨在评估术前气管切开术对晚期声门型喉癌患者肿瘤结局的影响,并探讨其潜在原因。
我们回顾性分析了 2005 年 1 月至 2010 年 12 月期间连续的 413 例晚期声门型喉癌患者。充分评估了术前气管切开术与肿瘤大小相关的潜在影响因素(肿瘤直径和肿瘤面积)与总生存期(OS)和无病生存期(DFS)的相关性。
本队列包括 302 例(73.1%)T3 患者和 111 例(26.9%)T4 患者,98 例(23.7%)患者接受了术前气管切开术。接受术前气管切开术的患者的 OS 和 DFS 率差于未接受者(5 年 OS:49.3%比 69.8%;5 年 DFS:45.3%比 61.0%)。术前气管切开术患者的平均肿瘤直径和肿瘤面积大于未接受者(3.3 cm 比 2.4 cm,8.9 cm 比 4.7 cm)。肿瘤直径和肿瘤面积的最佳截值为 2.85 cm 和 6.64 cm。肿瘤直径和肿瘤面积与气管切开术干预相关。此外,当考虑到肿瘤面积在多变量模型中的潜在影响时,我们发现它是生存结果的一个显著因素,但术前气管切开术变量不是。
本研究表明,肿瘤大小与术前气管切开术相关,气管切开术干预可能反映了肿瘤大小的影响,这是一个影响晚期声门型喉癌患者肿瘤结局的真正不利因素。